Rostock G, Faulhaber H D, Unger P, Homuth V, Prehm C, Günzel R
Pharmazie. 1985 Apr;40(4):259-61.
The relative bioavailability of two different Prazosine preparations (Adversuten, VEB Arzneimittelwerk Dresden, GDR and Minipress, Pfizer GmbH, Karlsruhe, FRG) has been determined in 10 patients suffering from an essential hypertension by the cross-over test following a single oral application. The plasma concentrations determined on the same conditions revealed with both the preparations an almost equal blood level course. The pharmacokinetic parameters had been determined to the one-compartment system, demonstrating not any significant differences. Compared to the Minipress, the relative bioavailability of the preparation Adversuten was calculated to 102%. The discussion enters into a possible influence on the distribution parameters by alterations of the kidney function.
通过单次口服后的交叉试验,在10例原发性高血压患者中测定了两种不同哌唑嗪制剂(Adversuten,民主德国德累斯顿VEB制药厂生产;Minipress,联邦德国卡尔斯鲁厄辉瑞有限公司生产)的相对生物利用度。在相同条件下测定的血浆浓度显示,两种制剂的血药浓度过程几乎相同。已对单室系统的药代动力学参数进行了测定,未显示出任何显著差异。与Minipress相比,Adversuten制剂的相对生物利用度经计算为102%。讨论涉及肾功能改变对分布参数可能产生的影响。